The triple blend adds the glycine component for patients who want comprehensive coverage of all three GLP-1 therapy concerns: efficacy, tolerability, and body composition
STEP program (Wegovy, obesity): Four Phase 3 trials demonstrating 15-17% mean weight loss with once-weekly 2.4 mg semaglutide
Whether your primary goal is type 2 diabetes management, weight loss, or both, Rybelsus offers a flexible, effective, and simple-to-use oral option
Warnings Keep out of the reach of children
This level of individualization is the hallmark of our practice
- Premium thermobox with cooling element Ensures temperature control during storage and transportation, which is critical for maintaining the drugs stability and efficacy